ARE Is Down - How Does the Market See the Stock?

Alexandria Real Estate Equities shares fell -4.1% this afternoon to a price of $128.98. The stock is still trading within range of its average target price of $131.92, and over the last 52 weeks, it has recorded a -7.2% performance. Analysts have given the large-cap Specialty Real Estate Investment Trust stock target prices ranging from $108.0 to $186.0 dollars per share, with an average rating of buy.

The stock has an average amount of shares sold short at 3.9%, and a short ratio of 4.88. The company's insiders own 0.83% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 98.0% of Alexandria Real Estate Equities's shares being owned by this investor type.

Institutions Invested in Alexandria Real Estate Equities

Date Reported Holder Percentage Shares Value
2023-09-30 Vanguard Group Inc 15% 26,767,277 $3,452,387,317
2023-09-30 Blackrock Inc. 10% 17,153,912 $2,212,475,637
2022-12-31 Norges Bank Investment Management 9% 15,632,151 $2,016,202,090
2023-09-30 State Street Corporation 6% 11,129,083 $1,435,405,812
2023-09-30 Apg Asset Management US Inc. 4% 7,177,446 $925,731,950
2023-09-30 Principal Financial Group, Inc. 4% 6,368,647 $821,414,749
2023-09-30 JP Morgan Chase & Company 3% 5,315,732 $685,611,978
2023-09-30 Canada Pension Plan Investment Board 2% 4,038,496 $520,876,754
2023-09-30 Geode Capital Management, LLC 2% 3,734,726 $481,697,136
2023-09-30 Victory Capital Management Inc. 2% 3,715,744 $479,248,877

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Alexandria Real Estate Equities.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.